The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $122.25

Today's change-0.15 -0.12%
Updated February 28 12:50 PM EST. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $122.25

Today's change-0.15 -0.12%
Updated February 28 12:50 PM EST. Delayed by at least 15 minutes.

Reversal following new 100-day high

Johnson & Johnson is lower today, dropping (U.S.)$0.15 or 0.12% to (U.S.)$122.25 after setting a new 100-day high. Over the last five days, shares have gained 2.16% and are currently 3.03% off of the 52-week high. Shares have underperformed the S&P 500 by 5.66% during the last year.

Key company metrics

  • Open(U.S.) $122.01
  • Previous close(U.S.) $122.40
  • High(U.S.) $122.65
  • Low(U.S.) $121.94
  • Bid / Ask(U.S.) $122.24 / (U.S.) $122.25
  • YTD % change+6.11%
  • Volume3,449,529
  • Average volume (10-day)7,350,138
  • Average volume (1-month)7,291,210
  • Average volume (3-month)7,296,098
  • 52-week range(U.S.) $105.04 to (U.S.) $126.07
  • Beta0.80
  • Trailing P/E20.59×
  • P/E 1 year forward17.39×
  • Forward PEG2.95×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.62%
  • Trailing EPS(U.S.) $5.94
Updated February 28 12:50 PM EST. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 01, 201701/01/2017Oct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016
Revenue18,10617,82018,48217,482
Total other revenue--------
Total revenue18,10617,82018,48217,482
Gross profit12,59012,35413,15312,170
Total cost of revenue5,5165,4665,3295,312
Total operating expense13,78212,53913,57812,188
Selling / general / administrative5,3094,7725,1764,688
Research & development2,6402,1792,2632,013
Depreciation / amortization--------
Interest expense (income), net operating--192190160
Unusual expense (income)29882150137
Other operating expenses, total-65-19593-37
Operating income4,3245,2814,9045,294
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4,3245,2814,9045,294
Income after tax3,8144,2723,9974,457
Income tax, total5101,009907837
Net income3,8144,2723,9974,457
Total adjustments to net income--------
Net income before extra. items3,8144,2723,9974,457
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,8144,2723,9974,457
Inc. avail. to common incl. extra. items3,8144,2723,9974,457
Diluted net income3,8144,2723,9974,457
Dilution adjustment--------
Diluted weighted average shares2,7652,7852,7942,798
Diluted EPS excluding extraordinary itemsvalue per share1.381.531.431.59
Dividends per sharevalue per share--0.800.800.75
Diluted normalized EPSvalue per share1.511.531.431.60